FindTrial
Sign In

To study lung fuction and residual lung damage in COVID 19 patients who recover from the infections.

Lung function impairment and injury in post COVID 19 infection - LIMPCov

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037090
Enrollment
400
Registered
2021-10-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A00-B99- Certain infectious and parasitic diseases Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Christian Medical College Vellore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult inpatients (more than 18 years and older) with positive SARS-CoV-2 RNA detection (throat swab) results and diagnosed with COVID-19 2. Willing to sign informed consent

Exclusion criteria

Exclusion criteria: 1. Patients not willing to consent or unable to come for follow-up.

Design outcomes

Primary

MeasureTime frame
1.Lung function paramenters: FEV1, FVC, TLC, RV, DLco, DLco/VA 2.6 Min walk test parameters: 6 min walk distance, Distance Saturation Product, Lowest SPO2, Dyspnea Borg scale 3.CXR/HRCT: Fibrosis, Consolidation, bronchiectasis etc. 4.SGRQ: Respirtory symptoms, problems, treatment & activities Timepoint: 4 to 6 weeks, 3 months, 6 months—

Secondary

MeasureTime frame
NilTimepoint: nil—

Countries

India

Contacts

Public ContactDevasahayam J Christopher

Christian Medical College

djchris@cmcvellore.ac.in09443306573

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026